TCM
TCG Crossover Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50M | Hold |
6,964,375
| – | – | 5.71% | 3 |
|
|
2025
Q1 | $41.7M | Hold |
6,964,375
| – | – | 5.69% | 2 |
|
|
2024
Q4 | $54.3M | Hold |
6,964,375
| – | – | 5.31% | 4 |
|
|
2024
Q3 | $75.2M | Hold |
6,964,375
| – | – | 6.37% | 3 |
|
|
2024
Q2 | $58.7M | Buy |
6,964,375
+750,000
| +12% | +$6.32M | 6.12% | 5 |
|
|
2024
Q1 | $41.8M | Buy |
6,214,375
+583,333
| +10% | +$3.92M | 3.3% | 12 |
|
|
2023
Q4 | $33.1M | Hold |
5,631,042
| – | – | 3.67% | 14 |
|
|
2023
Q3 | $54.9M | Hold |
5,631,042
| – | – | 8.08% | 2 |
|
|
2023
Q2 | $66.7M | Buy |
5,631,042
+2,000,000
| +55% | +$23.7M | 10.93% | 3 |
|
|
2023
Q1 | $39.2M | Hold |
3,631,042
| – | – | 7.64% | 2 |
|
|
2022
Q4 | $42M | Buy |
3,631,042
+150,000
| +4% | +$1.73M | 7.41% | 3 |
|
|
2022
Q3 | $51.9M | Hold |
3,481,042
| – | – | 15.58% | 2 |
|
|
2022
Q2 | $31.4M | Buy |
3,481,042
+500,000
| +17% | +$4.51M | 13.34% | 1 |
|
|
2022
Q1 | $22.3M | Buy |
2,981,042
+231,005
| +8% | +$1.73M | 8.96% | 3 |
|
|
2021
Q4 | $23.6M | Buy |
+2,750,037
| New | +$23.6M | 11.05% | 3 |
|